Ramy Abdelnaby: The Impact of Multiterritory Brain Infarcts on Recurrent Stroke Risk and Anticoagulation Efficacy
Ramy Abdelnaby, Consultant Neurologist / Oberarzt at RWTH Aachen University Hospital, shared on LinkedIn about a recent article by Rachel Gologorsky et al, published in Stroke Journal:
”A pivotal subgroup analysis of the ARCADIA trial, recently published in Stroke, illuminates the impact of multiterritory brain infarcts on recurrent stroke risk and the efficacy of anticoagulation in cryptogenic stroke patients.
The comprehensive study spanned from 2018 to 2022 across 185 centers, exploring atrial cardiopathy’s role in stroke recurrence and anticoagulation response.
Key findings reveal no significant association between atrial cardiopathy biomarkers, LVEF, and the number of infarct territories.
Yet, it’s the detailed examination of recurrent stroke risk and anticoagulation effects that promises to redefine clinical strategies.”
Title: Multiterritory Brain Infarcts, Anticoagulation, and Recurrence After Cryptogenic Stroke: A Subgroup Analysis of the ARCADIA Trial
Authors: Rachel Gologorsky, Maarten G. Lansberg, Max Wintermark, Christy N. Cassarly, Rebeca Aragon Garcia, Pamela Plummer, Nilushi Karunamuni, Scott E. Kasner, Babak B. Navi, Ava Liberman, Mukul Sharma, Joseph P. Broderick, W.T. Longstreth Jr., David L. Tirschwell, Richard A. Kronmal, Mitchell S.V. Elkind, Hooman Kamel
Read the Full Article on Stroke
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 30, 2026, 05:18Flora Peyvandi: Molecular and Lab Markers Linked to Bleeding Severity in Factor VII Deficiency
-
Oct 30, 2026, 05:11Rana Al-Hrout: Exploring Approach to Macrocytic Anemia
-
Oct 30, 2026, 04:22Francisco Chacón-Lozsán: Acute Pulmonary Embolism in 2026 – Blood Pressure Is Not the Same as Perfusion
-
Oct 30, 2026, 04:15Samin Mohsenian: Launching the PRO-RBDD-FX Registry for Rare Coagulation Factor X Deficiency
-
Oct 30, 2026, 03:59Emil List Larsen: Identifying SERPINC1 Variants and Limitations of Routine Antithrombin Testing
-
Oct 30, 2026, 02:43D Chandra: Reduce the Apixaban Dose for a Patient with VTE and a Creatinine Clearance of 25?
-
Oct 30, 2026, 02:38Spencer Dorn: Why AI Decision Support Must Integrate Local Clinical Context
-
Oct 30, 2026, 02:33Jens Eschen: Randomized Controlled Trial on Acute Aortic Dissection Anticoagulation Strategies
-
Oct 30, 2026, 02:23Mavis Agnes Kisakye: Landmark Study Paves the Way for Standardized Bleeding Disorder Guidelines in Uganda